Literature DB >> 35500952

Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.

Juan M Ramos-Goñi1, Mark Oppe2, Anabel Estévez-Carrillo2, Oliver Rivero-Arias3.   

Abstract

OBJECTIVES: The EuroQol Group published the EQ-5D-Y valuation protocol that recommends 2 valuation techniques to elicit preferences: composite time trade-off (C-TTO) and discrete choice experiments (DCEs). The protocol left the decision of what modeling approach to use open for researchers. Our aims were to explore modeling strategies allowing generation of EQ-5D-Y value sets and to produce an EQ-5D-Y Spanish value set.
METHODS: We used EQ-5D-Y DCE and C-TTO data collected in Spain following the protocol and adopted a staged approach for our modeling exercise. First, we selected the best performing DCE latent class model and evaluated models from 2 to 10 classes. We selected the preferred model based on best goodness of fit in terms of the Bayesian information criterion. We considered 2 anchoring approaches to estimate utility values: (1) pits state anchoring and (2) hybrid models (using all available C-TTO responses). All analysis were weighted to be representative of the Spanish population.
RESULTS: We collected 1005 DCE and 200 C-TTO interviews. We selected a DCE model including 4 classes. Hybrid models using all available C-TTO observations produced a narrower range of values than the pits state anchoring approach.
CONCLUSIONS: In this article, we have presented an EQ-5D-Y value set that can be used for cost-utility analysis in Spain. The international EQ-5D-Y valuation protocol should be updated to include a different set of health states for the C-TTO experiment if researchers wish to use alternative anchoring approaches to the "pits state."
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  EQ-5D-Y; composite time trade-off; discrete choice experiment; health-related quality of life; value set

Mesh:

Year:  2021        PMID: 35500952     DOI: 10.1016/j.jval.2021.10.013

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  6 in total

1.  Valuing EQ-5D-Y: the current state of play.

Authors:  N Devlin; T Pan; S Kreimeier; J Verstraete; E Stolk; K Rand; M Herdman
Journal:  Health Qual Life Outcomes       Date:  2022-07-06       Impact factor: 3.077

2.  In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.

Authors:  Stefan A Lipman; Brigitte A B Essers; Aureliano P Finch; Ayesha Sajjad; Peep F M Stalmeier; Bram Roudijk
Journal:  Pharmacoeconomics       Date:  2022-10-18       Impact factor: 4.558

3.  EQ-5D-Y Value Set for Germany.

Authors:  Simone Kreimeier; David Mott; Kristina Ludwig; Wolfgang Greiner
Journal:  Pharmacoeconomics       Date:  2022-05-23       Impact factor: 4.558

4.  Value Set for the EQ-5D-Y-3L in Hungary.

Authors:  Fanni Rencz; Gábor Ruzsa; Alex Bató; Zhihao Yang; Aureliano Paolo Finch; Valentin Brodszky
Journal:  Pharmacoeconomics       Date:  2022-09-20       Impact factor: 4.558

5.  A Value Set for the EQ-5D-Y-3L in the Netherlands.

Authors:  Bram Roudijk; Ayesha Sajjad; Brigitte Essers; Stefan Lipman; Peep Stalmeier; Aureliano Paolo Finch
Journal:  Pharmacoeconomics       Date:  2022-10-10       Impact factor: 4.558

6.  Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.

Authors:  Agata Łaszewska; Ayesha Sajjad; Jan Busschbach; Judit Simon; Leona Hakkaart-van Roijen
Journal:  Pharmacoeconomics       Date:  2022-10-06       Impact factor: 4.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.